ArticleVeterinary sciences2026
Assessment of Oxidative Stress and DNA Damage in Dogs with Visceral Leishmaniasis Using Urinary 8-Hydroxy-2'-Deoxyguanosine.
Article in Veterinary sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Canine leishmaniasis (CanL) is a major vector-borne disease with zoonotic potential, and oxidative stress plays an important role in its pathogenesis. CanL is a chronic, progressive disease in which clinical signs may develop gradually over months or even years, depending on host immune response and parasite burden. This study aimed to evaluate oxidative DNA damage in dogs with CanL by measuring urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels and oxidative stress markers. A total of 54 dogs, including 34 dogs with CanL and 20 healthy controls, were included. Urinary 8-OHdG and serum malondialdehyde (MDA) were measured using ELISA method, whereas serum TAC and TOC were determined using automated colorimetric method. Dogs with CanL showed significantly higher TAC (1.30 ± 0.05 vs. 1.04 ± 0.06 mmol/L,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.